Health Care: Drugs

Ligand Pharmaceuticals Inc (LGND: NASDAQ)

$51.88 -2.29 | -4.23%
08/21/14 - 03:10 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 48.97M 31.39M 30.04M 23.54M
Cost of Sales 2.65M 874.00K 3.82M 0.00
Gross Operating Profit 46.32M 30.51M 26.22M 23.54M
Selling, General, and Administrative Expenses 18.54M 16.11M 14.98M 29.72M
Research & Development 9.27M 10.79M 10.29M 22.07M
Operating Income before D & A (EBITDA) 18.50M 3.62M 948.00K -28.25M
Depreciation & Amortization 3.08M 2.73M 1.09M 510.00K
Interest Income 0.00 0.00 31.00K 440.00K
Other Income - Net -3.66M -1.13M 1.92M 15.22M
Special Income / Charges -480.00K -315.00K -2.26M -2.75M
Total Income Before Interest Expenses (EBIT) 11.28M -560.00K -444.00K -15.86M
Interest Expense 2.08M 3.30M 2.51M 58.00K
Pre-Tax Income 9.21M -3.86M -2.95M -15.91M
Income Taxes 374.00K -1.19M -13.12M -2.62M
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 8.83M -2.67M 10.17M -12.79M
Net Income From Discontinued Operations 2.59M 2.15M 3.00K 2.41M
Net Income From Total Operations 11.42M -527.00K 10.18M -10.37M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 11.42M -527.00K 10.18M -10.37M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
9.31M -2.36M 12.43M -10.03M
Preferred Dividends
Net Income Available To Common 8.83M -2.67M 10.17M -12.79M
Basic EPS from Continuing Ops. 0.43 -0.13 0.52 -0.65
Basic EPS from Discontinued Ops. 0.13 0.11 0.00 0.12
Basic EPS from Total Operations 0.56 -0.02 0.52 -0.53
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 -0.01 0.00 0.00
Basic EPS, Total 0.56 -0.03 0.52 -0.53
Basic Normalized Net Income/Share 0.45 -0.11 0.64 -0.51
EPS fr Continuing Ops. 0.43 -0.13 0.52 -0.65
EPS fr Discontinued Ops 0.12 0.11 0.00 0.12
EPS fr Total Ops. 0.55 -0.02 0.52 -0.53
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.01 0.00 0.00
EPS, Total 0.55 -0.03 0.52 -0.53
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.45 -0.12 0.63 -0.51
Dividends Paid per Share 0.00 0.00 0.00 0.46

Portfolios with LGND

Latest LGND Headlines from TheStreet

More Financial News for LGND

Press Releases for LGND

See All Press Releases

Partner Headlines for LGND

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter